Pancreatic Cancer Research

ResearcherTaipei Medical UniversityActive in the last 2 years

Alexander T.H. Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0178-6530; OpenAlex author ID A5064922397. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential. Last author DOI 10.7150/ijms.105193↗
  2. Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer. Co-author DOI 10.3390/cells9040911↗
  3. Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensi… Co-author DOI 10.1016/j.radonc.2018.07.012↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huong Thi Luu Kim Huynh · 1 shared paper, 2025 · strength 0.28
  2. Tsu-Yi Chao · 1 shared paper, 2020 · strength 0.13
  3. Chi‐Tai Yeh · 1 shared paper, 2020 · strength 0.13
  4. Shiue‐Wei Lai · 1 shared paper, 2020 · strength 0.13
  5. Szu‐Yuan Wu · 1 shared paper, 2018 · strength 0.09
  6. Yen‐Kuang Lin · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.